fda banning compounded semaglutide 🚨There's been a lot of confusion lately, so let's clear this up… Compounded GLP-1 medications (like semaglutide and tirzepatide) are not banned entirely — but access is changing. The FDA has ended

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide 1 receptor agonist therapy Scientific Reports GLP Pro GLP 1 Probiotic & Postbiotic (CS) Triquetra Glucagon like peptide 1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study The BMJ Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP 1 Secretion: Cell Reports Lilly's Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds Reuters